BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14739615)

  • 1. Discovery and development of anti-angiogenic peptides: A structural link.
    Dings RP; Nesmelova I; Griffioen AW; Mayo KH
    Angiogenesis; 2003; 6(2):83-91. PubMed ID: 14739615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
    Dhanabal M; Jeffers M; LaRochelle WJ; Lichenstein HS
    Biochem Biophys Res Commun; 2005 Jul; 333(2):308-15. PubMed ID: 15950186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A journey in structure-based drug discovery: from designed peptides to protein surface topomimetics as antibiotic and antiangiogenic agents.
    Dings RP; Mayo KH
    Acc Chem Res; 2007 Oct; 40(10):1057-65. PubMed ID: 17661438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches in anti-angiogenic treatment targeting endothelial F-actin: a new anti-angiogenic strategy?
    Thoenes L; Günther M
    Curr Opin Mol Ther; 2008 Dec; 10(6):579-90. PubMed ID: 19051136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide.
    Patel NS; Quadros A; Brem S; Wotoczek-Obadia M; Mathura VS; Laporte V; Mullan M; Paris D
    Amyloid; 2008 Mar; 15(1):5-19. PubMed ID: 18266117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinase inhibitors as anti-angiogenic agents.
    Kim DW; Lu B; Hallahan DE
    Curr Opin Investig Drugs; 2004 Jun; 5(6):597-604. PubMed ID: 15242247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
    Langenkamp E; Molema G
    Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 1. Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis.
    Cooke VG; Kalluri R
    Methods Enzymol; 2008; 444():1-19. PubMed ID: 19007658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization.
    Cai W; Ma J; Li C; Yang Z; Yang X; Liu W; Liu Z; Li M; Gao G
    J Cell Biochem; 2005 Dec; 96(6):1254-61. PubMed ID: 16167344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro and in-vivo assays for angiogenesis-modulating drug discovery and development.
    Phung MW; Dass CR
    J Pharm Pharmacol; 2006 Feb; 58(2):153-60. PubMed ID: 16451742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic vascular disease and solid cancers: opposing ends of the angiogenic spectrum?
    Balasubramanian SP; Reed MW
    Med Hypotheses; 2006; 67(6):1317-9. PubMed ID: 16828237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endostatin signaling and regulation of endothelial cell-matrix interactions.
    Wickström SA; Alitalo K; Keski-Oja J
    Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic antithrombin.
    O'Reilly MS
    Semin Thromb Hemost; 2007 Oct; 33(7):660-6. PubMed ID: 18000792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting angiogenesis with compounds from the extracellular matrix.
    Belotti D; Foglieni C; Resovi A; Giavazzi R; Taraboletti G
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1674-85. PubMed ID: 21864705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new family of angiogenic factors.
    Martínez A
    Cancer Lett; 2006 May; 236(2):157-63. PubMed ID: 15927357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic gene therapy of cancer: current status and future prospects.
    Persano L; Crescenzi M; Indraccolo S
    Mol Aspects Med; 2007 Feb; 28(1):87-114. PubMed ID: 17306361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.